Skip Nav Destination
Modern Trends in Psychiatry
Anxiety Disorders
S.Karger AG
Volume
29
Status:
Available
ISBN electronic:
978-3-318-02464-7
ISBN print:
978-3-318-02463-0
Book Series:
Modern Trends in Psychiatry
Publication date:
2013
Book Details
Anxiety disorders are not uncommon and are often ‘comorbid’ with other forms of mental disorders. This publication provides an update on the origins and the causes of anxiety disorders and their related symptoms. Its focus is on neuroimaging and neuroinflammation and genetics as well as areas where an overlap may exist with abnormal cardiovascular physiology. Further it takes a closer look at the early phases of anxiety disorder and the potential effects of prolonged illness prior to diagnosis and also investigates recent research findings about the neuroimmunology of depression and the immunomodulatory effects of antidepressants. It also examines the neuroinflammatory hypothesis about anxiety disorders and concludes with the succinct but evidence-based and comprehensive reports on the value of pharmacological treatments used for generalized anxiety disorder, panic disorder, social anxiety disorder, posttraumatic stress disorder and obsessive-compulsive disorder. The topics covered in this publication will certainly make it essential reading for both novice and expert practitioners in psychiatric medicine, but its appeal should extend even further and include those researching the neuropsychobiology of anxiety or trying to improve our grasp of posttraumatic stress disorder or obsessive-compulsive disorder.
Anxiety Disorders
Edited by: B.E. Leonard, D.S. Baldwin
https://doi.org/10.1159/isbn.978-3-318-02464-7
ISBN (print): 978-3-318-02463-0
ISBN (electronic): 978-3-318-02464-7
Publisher: S.Karger AG
Published: 2013
Download citation file:
Digital Version
Pay-Per-View Access
$115.00
Print Version
Anxiety Disorders
$115.00
Table of Contents
-
1 - 15: On the Nature of Obsessions and CompulsionsBySanneke de Haan;Sanneke de HaanaDepartment of Psychiatry, Academic Medical Center, andSearch for other works by this author on:Erik Rietveld;Erik RietveldaDepartment of Psychiatry, Academic Medical Center, andbDepartment of Philosophy, University of Amsterdam,Search for other works by this author on:Damiaan DenysDamiaan DenysaDepartment of Psychiatry, Academic Medical Center, andcThe Netherlands Institute for Neuroscience, The Royal Netherlands Academy of Arts and Sciences, Amsterdam, The NetherlandsSearch for other works by this author on:
-
16 - 23: The Origin of Anxiety Disorders - An Evolutionary ApproachByLisette E.W.G. Willers;Lisette E.W.G. WillersbDepartment of Psychiatry, University of Amsterdam, Amsterdam, The NetherlandsSearch for other works by this author on:Nienke C. Vulink;Nienke C. VulinkbDepartment of Psychiatry, University of Amsterdam, Amsterdam, The NetherlandsSearch for other works by this author on:Damiaan Denys;Damiaan DenysbDepartment of Psychiatry, University of Amsterdam, Amsterdam, The NetherlandsSearch for other works by this author on:Dan J. SteinDan J. SteinaDepartment of Psychiatry, University of Cape Town, Cape Town, South Africa, andSearch for other works by this author on:
-
24 - 46: Genetic Factors in Anxiety DisordersByKatharina Domschke;Katharina DomschkeaDepartment of Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Würzburg, Germany;Search for other works by this author on:Eduard MaronEduard MaronbDepartment of Neuropsychopharmacology and Molecular Imaging, Imperial College London, London, UK;cDepartment of Psychiatry, University of Tartu, Tartu, EstoniaSearch for other works by this author on:
-
47 - 66: Neuroimaging in Anxiety DisordersByMats Fredrikson;Mats FredriksonDepartment of Psychology, Uppsala University, Uppsala, SwedenSearch for other works by this author on:Vanda FariaVanda FariaDepartment of Psychology, Uppsala University, Uppsala, SwedenSearch for other works by this author on:
-
67 - 84: Potential Neuroimmunological Targets in the Treatment of Anxiety DisordersByRuihua Hou;Ruihua HouaUniversity Department of Psychiatry, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK;Search for other works by this author on:Zhen Tang;Zhen TangbSuzhou University Guangji Hospital, Suzhou, China;Search for other works by this author on:David S. BaldwinDavid S. BaldwinaUniversity Department of Psychiatry, Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK;cDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, South AfricaSearch for other works by this author on:
-
85 - 97: Anxiety and Cardiovascular DiseaseBySimon J.C. Davies;Simon J.C. DaviesaGeriatric Psychiatry Division, Centre for Addiction and Mental Health, Department of Psychiatry, University of Toronto, Toronto, Ont., Canada;bAcademic Unit of Psychiatry, University of Bristol, Bristol, UK;Search for other works by this author on:Christer AllgulanderChrister AllgulandercSection of Psychiatry, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, SwedenSearch for other works by this author on:
-
98 - 110: The Early Phases of Anxiety Disorders: From Prevention to TreatmentByJavier Vázquez-Bourgon;Javier Vázquez-BourgonDepartment of Psychiatry, Psychiatric Research Unit of Cantabria, University Hospital Marqués de Valdecilla, IFIMAV, CIBERSAM, Santander, SpainSearch for other works by this author on:Andres Herrán;Andres HerránDepartment of Psychiatry, Psychiatric Research Unit of Cantabria, University Hospital Marqués de Valdecilla, IFIMAV, CIBERSAM, Santander, SpainSearch for other works by this author on:José Luis Vázquez-BarqueroJosé Luis Vázquez-BarqueroDepartment of Psychiatry, Psychiatric Research Unit of Cantabria, University Hospital Marqués de Valdecilla, IFIMAV, CIBERSAM, Santander, SpainSearch for other works by this author on:
-
111 - 118: Duration of Untreated Illness and Duration of Illness in Anxiety Disorders: Assessment and Influence on OutcomeByA. Carlo Altamura;A. Carlo AltamuraDepartment of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, ItalySearch for other works by this author on:Giulia Camuri;Giulia CamuriDepartment of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, ItalySearch for other works by this author on:Bernardo Dell'OssoBernardo Dell'OssoDepartment of Psychiatry, University of Milan, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, ItalySearch for other works by this author on:
-
119 - 127: Pharmacotherapy of Generalized Anxiety DisorderByChrister Allgulander;Christer AllgulanderaSection of Psychiatry, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden;Search for other works by this author on:David S. BaldwinDavid S. BaldwinbUniversity Department of Psychiatry, University of Southampton, Southampton, UK;cDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, South AfricaSearch for other works by this author on:
-
128 - 143: Pharmacological Treatment of Panic DisorderByBorwin Bandelow;Borwin BandelowaDepartment of Psychiatry and Psychotherapy, University of Göttingen, Göttingen, andSearch for other works by this author on:David S. Baldwin;David S. BaldwincClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK;dDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, South AfricaSearch for other works by this author on:Peter ZwanzgerPeter ZwanzgerbDepartment of Psychiatry and Psychotherapy, University of Münster, Münster, Germany;Search for other works by this author on:
-
144 - 153: Pharmacological Treatment of Social Anxiety DisorderByVasilios G. Masdrakis;Vasilios G. MasdrakisaFirst Department of Psychiatry, Eginition Hospital, Athens University Medical School, Athens, Greece;Search for other works by this author on:Darko Turic;Darko TuricbClinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK;Search for other works by this author on:David S. BaldwinDavid S. BaldwinbClinical and Experimental Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, UK;cDepartment of Psychiatry and Mental Health, University of Cape Town, Cape Town, South AfricaSearch for other works by this author on:
-
154 - 163: Pharmacotherapy of Posttraumatic Stress DisorderByAnthony Koller;Anthony KollerDepartment of Psychiatry, University of Cape Town, Cape Town, South AfricaSearch for other works by this author on:Dan J. SteinDan J. SteinDepartment of Psychiatry, University of Cape Town, Cape Town, South AfricaSearch for other works by this author on:
-
164 - 177: Evidence-Based Treatment Pathways for Translational Studies in Obsessive-Compulsive DisordersByN.A. Fineberg;N.A. FinebergaNational Obsessive Compulsive Disorders Specialist Service, Hertfordshire Partnership University NHS Foundation Trust, Queen Elizabeth II Hospital, Welwyn Garden City,bPostgraduate Medical School, University of Hertfordshire, College Lane, Hatfield, andcUniversity of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Cambridge, UK;Search for other works by this author on:S. Pallanti;S. PallantidUniversity of Florence, Florence, Italy;eMount Sinai Hospital Medical School, New York, N.Y., USASearch for other works by this author on:S. ReghunandananS. ReghunandananaNational Obsessive Compulsive Disorders Specialist Service, Hertfordshire Partnership University NHS Foundation Trust, Queen Elizabeth II Hospital, Welwyn Garden City,Search for other works by this author on:
